Genetic insights into the clinical diversity of β thalassaemia

British Journal of Haematology

Volumn 124, Issue 3, 2004, Pages 264-274

  Thein, Swee Lay ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

thalassaemia; Genotype phenotype correlation

Indexed keywords

BETA GLOBIN; HEMOGLOBIN F;

ALLELE; BETA THALASSEMIA; CLINICAL GENETICS; DISEASE SEVERITY; DOMINANT INHERITANCE; GALLSTONE FORMATION; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE STRUCTURE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HEART DISEASE; HUMAN; HYPERBILIRUBINEMIA; MOLECULAR GENETICS; MOSAICISM; OSTEOPENIA; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; REVIEW;

ALLELES; BETA-THALASSEMIA; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES; GLOBINS; HUMANS; PHENOTYPE;

EID: 0842308839     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04769.x     Document Type: Review

References (76)

1. Anapliotou, M.L., Kastanias, I.T., Psara, P., Evangelou, E.A., Liparaki, M. & Dimitriou, P. (1995) The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches. Clinical Endocrinology, 42, 279-287.
2. Andrews, N. (2000) Iron homeostasis: insights from genetics and animal models. Nature Reviews Genetics, 1, 208-216.
3. Andrews, N.C. (2002) A genetic view of iron homeostasis. Seminars in Hematology, 39, 227-234.
4. Antoniou, M., deBoer, E., Habets, G. & Grosveld, F. (1988) The human β-globin gene contains multiple regulatory regions: identification of one promoter and two downstream enhancers. EMBO Journal, 7, 377-384.
5. Badens, C., Mattei, M.G., Imbert, A.M., Lapoumérouliee, C., Martini, N., Michel, G. & Lena-Russo, D. (2002) A novel mechanism for thalassaemia intermedia. The Lancet, 359, 132-133.
6. Bertoldo, F., D'Agruma, L., Furlan, F., Colapietro, F., Lorenzi, M.T., Maiorano, N., Iolascon, A., Zelante, L., Locascio, V. & Gasparini, P. (2000) Transforming growth factor-beta1 gene polymorphism, bone turnover, and bone mass in Italian postmenopausal women. Journal of Bone and Mineral Research, 15, 634-639.
7. Bosma, P.J., Chowdhury, J.R., Bakker, C., Gantla, S., De Boer, A., Oostra, B.A., Lindhout, D., Tytgat, G.N.J., Jansen, P.L.M., Elferink, R.P.J.O. & Chowdhury, N.R. (1995) The genetic basis of the reduced expression of bilirubin UCP-glucuronosultransferase 1 in Gilbert's syndrome. New England Journal of Medicine, 333, 1171-1175.
8. Boyer, S.H., Belding, T.K., Margolet, L. & Noyes, A.N. (1975) Fetal hemoglobin restriction to a few erythrocytes (F cells) in normal human adults. Science, 188, 361-363.
9. Bulger, M., Bender, M.A., van Doorninck, J.H., Wertman, B., Farrell, C.M., Felsenfeld, G., Groudine, M. & Hardison, R. (2000) Comparative structural and functional analysis of the olfactory receptor genes flanking the human and mouse beta-globin gene clusters. PNAS, 97, 14560-14565.
10. Bunn, H.F. & Forget, E.G. (1986) Hemoglobin: Molecular, Genetic and Clinical Aspects. W.B. Saunders Company, Philadelphia, PA.
11. Camaschella, C., Maza, U., Roetto, A., Gottardi, E., Parziale, A., Travi, M., Fattore, S., Bacchiega, D., Fiorelli, G. & Cappellini, M.D. (1995) Genetic interactions in thalassemia intermedia: analysis of beta-mutations, alpha-genotype, gamma-promoters, and beta-LCR hypersensitive sites 2 and 4 in Italian patients. American Journal of Hematology, 48, 82-87.
12. Camaschella, C., Kattamis, A.C., Petroni, D., Roetto, A., Sivera, P., Sbaiz, L., Cohen, A., Ohene-Frempong, K., Trifillis, P., Surrey, S. & Fortina, P. (1997) Different hematological phenotypes caused by the interaction of triplicated alpha-globin genes and heterozygous beta-thalassemia. American Journal of Hematology, 55, 83-88.
13. Carter, D., Chakalova, L., Osborne, C.S., Dai, Y.F. & Fraser, P. (2002) Long-range chromatin regulatory interactions in vivo. Nature Genetics, 32, 623-626.
14. Collins, F.S. & Weissman, S.M. (1984) The molecular Genetics of human hemoglobin. Progress in Nucleic Acid Research and Molecular Biology, 31, 315-465.
15. 2. British Journal of Haematology, 82, 735-744.
16. Craig, I.E., Rochette, I., Fisher, C.A., Weatherall, D.J., Marc, S., Lathrop, G.M., Demenais, F. & Thein, S.L. (1996) Dissecting the loci controlling fetal haemoglobin production on chromosomes lip and 6q by the regressive approach. Nature Genetics, 12, 58-64.
17. Divoky, V., Indrak, K., Mrug, M., Brabec, V., Huisman, T.H.J. & Prchal, J.T. (1996) A novel mechanism of β thalassemia: The insertion of L1 retrotransposable element into β globin IVS II. Blood, 88, 148a.
18. Dover, G.J., Smith, K.D., Chang, Y.C., Purvis, S., Mays, A., Meyers, D.A., Sheils, C. & Serjeant, G. (1992) Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2. Blood, 80, 816-824.
19. Dresner Pollack, R., Rachmilewitz, E., Blumenfdd, A., Idelson, M. & Goldfarb, A.W. (2000) Bone mineral metabolism in adults with beta-thalassaemia major and intermedia. British Journal of Haematology, 111, 902-907.
20. Economou-Peterson, E., Aesspopos, A., Kladi, A., Flevari, P., Karabatsos, F., Fragodimitri, C., Nicolaidis, P., Vrettou, H., Vassilopoulos, D., Karagiorga-Lagana, M., kremastinos, D.T. & Petersen, M.B. (1998) Apolipoprotein E epsilon4 allele as a genetic risk factor for left ventricular failure in homozygous beta-thalassemia. Blood, 92, 3455-3459.
21. Efstratiadis, A., Posakony, J.W., Maniatis, T., Lawn, R.M., O'Connell, C., Spritz, R.A., DeRiel, J.K., Forget, E.G., Weissman, S.M., Slightom, J.L., Blechl, A.E., Smithies, O., Baralle, F.E., Shoulders, C.C. & Proudfoot, N.J. (1980) The structure and evolution of the human beta-globin gene family. Cell, 21, 653-668.
22. Eldor, A. & Rachmilewitz, E.A. (2002) The hypercoagulable state in thalassemia. Blood, 99, 36-43.
23. Fei, Y.J., Stoming, T.A., Kutlar, A., Huisman, T.H.J. & Stamatoyannopoulos, G. (1989) One form of inclusion body β-thalassemia is due to a GAA-〉TAA mutation at codon 121 of the β chain. Blood, 73, 1075-1077.
24. Flint, J., Harding, R.M., Boyce, A.J. & Clegg, J.B. (1998) The population genetics of the haemoglobinopathies. In: Bailliére's Clinical Haematology (ed. by G.P. Rodgers), Vol. 11, pp. 1-52. Bailliere Tindall, London.
25. Galanello, R., Ruggeri, R., Paglietti, E., Addis, M., Melis, M.A. & Cao, A. (1983) A family with segregating triplicated alpha globin loci and β thalassaemia. Blood, 62, 1035-1040.
26. Galanello, R., Dessi, E., Melis, M.A., Addis, M., Sanna, M.A., Rosatelli, C., Argiolu, F., Giagu, N., Turco, M.P., Cacace, E., Pirastu, M. & Cao, A. (1989) Molecular analysis of beta zero-thalassemia intermedia in Sardinia. Blood, 74, 823-827.
27. Galanello, R., Perseu, L., Melis, M.A., Cipollina, L., Barella, S., Giagu, N., Turco, M.P., Maccioni, O. & Cao, A. (1997) Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome. British Journal of Haematology, 99, 433-436.
28. Galanello, R., Piras, S., Barella, S., Leoni, G.B., Cipollina, M.D., Perseu, L. & Cao, A. (2001) Cholelithiasis and Gilbert's syndrome in homozygous beta-thalassaemia. British Journal of Haematology, 115, 926-928.
29. Garner, C., Tatu, T., Reittie, J.E., Littlewood, T., Darley, J., Cervino, S., Farrall, M., Kelly, P., Spector, T.D. & Thein, S.L. (2000a) Genetic influences on F cells and other hematological variables: a twin heritability study. Blood, 95, 342-346.
30. Garner, C., Tatu, T., Game, L., Cardon, L.R., Spector, T.D., Farrall, M. & Thein, S.L. (2000b) A candidate gene study of F cell levels in sibling pairs using a joint linkage and association analysis. GeneScreen, 1, 9-14.
31. Garner, C.P., Tatu, T., Best, S., Creary, L. & Thein, S.L. (2002) Evidence for Genetic Interaction between the beta-globin complex and chromosome 8q in the expression of fetal hemoglobin. American Journal of Human Genetics, 70, 793-799.
32. Gianni, A.M., Bregni, M., Cappellini, M.D., Fiorelli, G., Taramelli, R., Giglioni, B., Comi, P. & Ottolenghi, S. (1983) A gene controlling fetal hemoglobin expression in adults is not linked to the non-alpha globin cluster. EMBO Journal, 2, 921-925.
33. Gonzalez-Redondo, J.M., Stoming, T.A., Kutlar, A., Kutlar, F., Lanclos, K.D., Howard, E.F., Fei, Y.J., Aksoy, M., Altay, C., Gurgey, A., Basak, A.N., Efremov, G.D., Petkov, G. & Huisman, T.H.J. (1989) A C → T substitution at nt-101 in a conserved DNA sequence of the promoter region of the β-globin gene is associated with 'silent' β-thalassemia. Blood, 73, 1705-1711.
34. Grant, S.F., Reid, D.M., Blake, G., Herd, R., Fogelman, I. & Ralston, S.H. (1996) Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nature Genetics, 14, 203-205.
35. Hall, G.W. & Thein, S.L. (1994) Nonsense codon mutations in the terminal exon of the β-globin gene are not associated with a reduction in β-mRNA accumulation: a mechanism for the phenotype of dominant β-thalassemia. Blood, 83, 2031-2037.
36. Hentze, M.W. & Kulozik, A.E. (1999) A perfect message: RNA surveillance and nonsense-mediated decay. Cell, 96, 307-310.
37. Ho, P.J., Wickramasinghe, S.N., Rees, D.C., Lee, M.J., Eden, A. & Thein, S.L. (1997) Erythroblastic inclusions in dominantly inherited β thalassaemias. Blood, 89, 322-328.
38. Ho, P.J., Hall, G.W., Luo, L.V., Weatherall, D.J. & Thein, S.L. (1998) Beta thalassemia intermedia: is it possible to consistently predict phenotype from genotype? British Journal of Haematology, 100, 70-78.
39. 2 in heterozygotes and homozygotes for beta-thalassemia mutations: Influence of mutations in the CACCC and ATAAA motifs of the beta-globin gene promoter. Acta Haematologica, 98, 187-194.
40. Jensen, C.E., Tuck, S.M., Agnew, J.E., Koneru, S., Morris, R.W., Yardumian, A., Prescott, E., Hoffbrand, A.V. & Wonke, B. (1998) High prevalence of low bone mass in thalassaemia major. British Journal of Haematology, 103, 911-915.
41. Kihm, A.J., Kong, Y., Hong, W., Russell, J.E., Rouda, S., Adachi, K., Simon, M.C., Blobel, G.A. & Weiss, M.J. (2002) An abundant erythroid protein that stabilizes free alpha-haemoglobin. Nature, 417, 758-763.
42. Labie, D., Pagnier, J., Lapoumeroulie, C., Rouabhi, F., Dunda-Belkhodja, O., Chardin, P., Beldjord, C., Wajcman, H., Fabry, M.E. & Nagel, R.L. (1985) Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients. Proceedings of the National Academy of Sciences of the United States of America, 82, 2111-2114.
43. Maquat, L.E. (1995) When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. RNA, 1, 453-465.
44. Maragoudaki, E., Kanavakis, E., Trager-Synodinos, J., Vrettou, C., Tzetis, M., Metxotou-Mavrommati, A. & Kattamis, C. (1999) Molecular, haematological and clinical studies of the -101 C → T substitution in the β-globin gene promoter in 25 β-thalassaemia intermedia patients and 45 heterozygotes. British Journal of Haematology, 107, 699-706.
45. Melis, M.A., Cau, M., Deidda, F., Barella, S., Cao, A. & Galanello, R. (2002) H63D mutation in the HFE gene increases iron overload in beta-thalassemia carriers. Haematologica, 87, 242-245.
46. Merryweather-Clarke, A.T., Pointon, J.J., Shearman, J.D. & Robson, K.J.H. (1997) Global prevalence of putative haemochromatosis mutations. Journal of Medical Genetics, 34, 275-278.
47. Passon, R.G., Howard, T.A., Zimmerman, S.A., Schultz, W.H. & Ware, R.E. (2001) Influence of bilirubin uridine diphosphate-glucuronosyltransferase 1A promoter polymorphisms on serum bilirubin levels and cholelithiasis in children with sickle cell anemia. American Journal of Pediatric Hematology and Oncology, 23, 448-451.
48. Perrotta, S., Cappellini, M.D., Bertoldo, F., Servedio, V., Iolascon, G., D'Agruma, L., Gasparini, P., Siciliani, M.C. & Iolascon, A. (2000) Osteoporosis in beta-thalassaemia major patients: analysis of the genetic background. British Journal of Haematology, 111, 461-466.
49. Piperno, A., Mariani, R., Arosio, C., Vergani, A., Bosio, S., Fargion, S., Sampietro, M., Girelli, D., Fraquelli, M., Conte, D., Fiorelli, G. & Camaschella, C. (2000) Haemochromatosis in patients with beta-thalassaemia trait. British Journal of Haematology, 111, 908-914.
50. Pocock, N.A., Eisman, J.A., Hopper, J.L., Yeates, M.G., Sambrook, P.N. & Eberl, S. (1987) Genetic determinants of bone mass in adults. A twin study. Journal of Clinical Investigation, 80, 706-710.
51. Rees, D.C., Luo, L.Y., Thein, S.L., Sing, B.M. & Wickramasinghe, S. (1997) Nontransfusional iron overload in thalassemia: Association with hereditary hemochromatosis. Blood, 90, 3234-3236.
52. Rund, D., Filon, D., Strauss, N., Rachmilewitz, E.A. & Oppenheim, A. (1991) Mean corpuscular volume of heterozygotes for β-thalassemia correlates with the severity of mutations. Blood, 79, 238-243.
53. Sampietro, M., Lupica, L., Perrero, L., Comino, A. & Martinez di Montemuros, F. (1997) The expression of uridine diphosphate glucuronosyltransferase gene is a major determinant of bilirubin level in heterozygous beta-thalassaemia and in glucose-6-phosphate. British Journal of Haematology, 99, 437-439.
54. Schokker, R.C., Went, L.N. & Bok, J. (1966) A new genetic variant of β-thalassaemia. Nature, 209, 44-46.
55. Schrier, S.L. (2002) Pathophysiology of thalassemia. Current Opinion in Hematology, 9, 123-126.
56. Skarmoutsou, C., Papassotiriou, I., Traeger-Synodinos, J., Stamou, H., Ladis, V., Metaxotou-Mavrommati, A., Stamoulakatou, A. & Kanavakis, E. (2003) Erythroid bone marrow activity and red cell hemoglobinization in iron sufficient beta-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin in content. Correlation with genotypes and Hb A2 levels. Haematologica, 88, 631-636.
57. Slemenda, C.W., Christian, J.C., Williams, C.J., Norton, J.A. & Johnston Jr, C.C. (1991) Genetic determinants of bone mass in adult women: a re-evaluation of the twin model and the potential importance of gene interaction on heritability estimates. Journal of Bone and Mineral Research, 6, 561-567.
58. Soroko, S.B., Barrett-Connor, E., Edelstein, S.L. & Kritz-Silverstein, D. (1994) Family history of osteoporosis and bone mineral density at the axial skeleton: the Rancho Bernardo Study. Journal of Bone and Mineral Research, 9, 761-769.
59. Thein, S.L. (1992) Dominant beta thalassaemia: molecular basis and pathophysiology. British Journal of Haematology, 80, 273-277.
60. Thein, S.L. (1998) Beta thalassaemia. In: Bailliere's Clinical Haematology, Sickle Cell Disease and Thalassaemia (ed. by G.P. Rodgers), Vol. 11:1, pp. 91-126. Baillière Tindall, London.
61. Thein, S.L. (1999) Is it dominantly inherited beta thalassaemia or just a beta-chain variant that is highly unstable? British Journal of Haematology, 107, 12-21.
62. Thein, S.L. (2001) Structural variants with a beta-thalassemia phenotype. In: Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management (ed. by M.H. Steinberg, B.C. Forget, D.R. Higgs & R.L. Nagel), pp. 342-355. Cambridge University Press, Cambridge, UK.
63. Thein, S.L. & Craig, J.E. (1998) Genetics of Hb F/F cell variance in adults and heterocellular hereditary persistence of fetal hemoglobin. Hemoglobin, 22, 401-414.
64. Thein, S.L. & Weatherall, D.J. (1989) A non-deletion hereditary persistance of fetal hemoglobin (HPFH) determinant not linked to the beta-globin gene complex. In: Hemoglobin Switching, Part B: Cellular and Molecular Mechanisms (ed. by G. Stamatoyannopoulos & A.W. Nienhuis), pp. 97-111. Alan R Liss, Inc., New York, NY.
65. Thein, S.L., Al-Hakim, I. & Hoffbrand, A.V. (1984) Thalassaemia intermedia: a new molecular basis. British Journal of Haematology, 56, 333-337.
66. Thein, S.L., Wainscoat, J.S., Sampietro, M., Old, J.M., Cappellini, D., Fiorelli, G., Modell, B. & Weatherall, D.J. (1987) Association of thalassaemia intermedia with a beta-globin gene haplotype. British Journal of Haematology, 65, 367-373.
67. Tolhuis, B., Palstra, R.J., Splinter, E., Grosveld, F. & de Laat, W. (2002) Looping and interaction between hypersensitive sites in the active beta-globin locus. Molecular Cell, 10, 1453-1465.
68. Traeger-Synodinos, J., Kanavakis, E., Vrettou, C., Maragoudaki, E., Michael, T. & Metaxotou-Mavromati, A. (1996) The triplicated alpha-globin gene locus in beta-thalassaemia heterozygotes: clinical, haematological, biosynthetic and molecular studies. British Journal of Haematology, 95, 467-471.
69. Trudel, M. & Costantini, F. (1987) A 3'enhancer contributes to the stage-specific expression of the human β-globin gene. Genes and Development, 1, 954-961.
70. Viprakasit, V., Gibbons, R.J., Broughton, B.C., Tolmie, J.L., Brown, D., Lunt, P., Winter, R.M., Marinoni, S., Stefanini, M., Brueton, L., Lehmann, A.R. & Higgs, D.R. (2001) Mutations in the general transcription factor TFIIH result in beta-thalassaemia in individuals with trichothiodystrophy. Human Molecular Genetics, 10, 2797-2802.
71. Weatherall, D.J. & Clegg, J.B. (2001) The Thalassaemia Syndromes, 4th edn. Blackwell Science, Oxford.
72. Weatherall, D.J., Clegg, J.B., Knox-Macaulay, H.H.M., Bunch, C., Hopkins, C.R. & Temperley, I.J. (1973) A genetically determined disorder with features both of thalassaemia and congenital dyserythropoietic anaemia. British Journal of Haematology, 24, 681-702.
73. Wong, C., Dowling, C.E., Saiki, R.K., Higuchi, R.G., Erlich, H.A. & Kazazian, H.H.J. (1987) Characterization of beta-thalassaemia mutations using direct genomic sequencing of amplified single copy DNA. Nature, 330, 384-386.
74. Wonke, B. (1998) Bone disease in beta-thalassaemia major. British Journal of Haematology, 103, 897-901.
75. Wood, W.G. (2001) Hereditary persistence of fetal hemoglobin and delta beta thalassemia. In: Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management (ed. by M.H. Steinberg, B.C. Forget, D.R. Higgs & R.L. Nagel), pp. 356-388. Cambridge University Press, Cambridge, UK.
76. Yu, C., Niakan, K.K., Matsushita, M., Stamatoyannopoulos, G., Orkin, S.H. & Raskind, W.H. (2002) X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. Blood, 100, 2040-2045.